The Africa Centres for Disease Control and Prevention says the AstraZeneca vaccines that South Africa sold to the African Union have now been distributed to other countries across the continent.
Health Minister Dr Zweli Mkhize says the global coronavirus vaccine rollout has suffered a major blow due to high demand of vaccines throughout the world.
Some experts say government still has no concrete vaccine rollout plan and is still way off its target of vaccinating healthcare workers.
DA leader John Steenhuisen has called on President Cyril Ramaphosa to explain the rationale behind government's sale of the Astrazeneca COVID-19 vaccines that arrived in the country in February.
No countries in Africa have refused the AstraZeneca COVID-19 vaccine due to any remaining health concerns, a senior official of the World Health Organisation (WHO) said on Monday.
Health Minister, Zweli Mkhize has confirmed that government has concluded its sale of one million doses of the AstraZeneca coronavirus vaccine that arrived in the country in the middle of last month
The Department of Health says another batch of the Johnson & Johnson COVID-19 vaccine has arrived in South Africa.
The World Health Organisation is briefing the media on the latest developments in the fight against COVID-19.
Very few side-effects have been reported so far among the more than 177 000 healthcare workers who have received the COVID-19 Johnson and Johnson vaccines.
Chairperson of the Inter-Ministerial Committee on COVID-19 Vaccines, Deputy President David Mabuza, is visiting the Biovac Institute in Pinelands in the Western Cape on Thursday as government further explores the manufacturing of coronavirus vaccines in South Africa.
South Africa will next month receive 20 million vaccine doses from Pfizer-BioNTech, but its efficacy rate against the dominant COVID-19 variant found in South Africa is not conclusive, says vice-president for Research at SAMRC, Professor Jeffrey Mphahlele.
A South African study of the Oxford-AstraZeneca vaccine trial has indicated that the vaccine does not have the required 60 percent efficacy against the variant of the coronavirus found in South Africa.
Deputy President David Mabuza has answered questions in the National Assembly on a wide range of issues. These included load shedding and Eskom's turnaround strategy as well as what measures are in place to ensure that the acquisition of COVID-19 vaccines will not be tainted by corruption.
Most developed countries are in the advanced stages of COVID-19 vaccination rollouts. But a large number of developing countries, including most across Africa, are still at the early stages, mainly due to a shortage of shots.
The South African Health Products Authority (SAHPRA) has voiced cautious optimism over the efficacy of the Pfizer/BioNTech vaccine against new variants of the coronavirus.
Health product regulator SAHPRA has approved a Section 21 emergency use application for the COVID-19 vaccine developed by Pfizer and BioNTech.
Gauteng has depleted its stock of the Johnson and Johnson COVID-19 vaccine for healthcare workers. Thirty-one thousand healthcare workers have been vaccinated in the province since the arrival of the first two batches totalling 160 000 doses of J&J vaccines arrived in the country last month.
Deputy President David Mabuza has assured Parliament that government has taken extensive measures to ensure there is no corruption in the procurement and distribution of COVID-19 vaccines. Mabuza says these measures include the centralisation of procurement and distribution.
GAVI - The Vaccine Alliance says that manufacturing capacity is one of the major constraints facing the COVAX facility, which is a global initiative aimed at equitable access and distribution of COVID-19 vaccines.
Chairperson of the Ministerial Advisory Committee on Vaccines Professor Barry Schoub condemned reports that some people are fraudulently registering in order to get vaccinated.
Deputy Health Minister Dr. Joe Phaahla's response to opposition parties in Parliament on Friday, that the Johnson and Johnson COVID-19 vaccine that is being administered to health workers has not been formally registered with the South African Health Products Regulatory Authority (SAHPRA), has put a spotlight on vaccine licensing.
Phase two of South Africa's coronavirus (COVID-19) vaccine rollout could begin at the end of April. To date, over a hundred thousand healthcare workers have been vaccinated in phase one of the Johnson& Johnson vaccine drive.
Health experts are supporting government’s decision to administer the Johnson and Johnson COVID-19 vaccine to healthcare workers before it is registered.
The Department of Health says it is pleased that more than 100 000 healthcare workers have been vaccinated in just over two weeks with the early access Johnson and Johnson vaccine. South Africa yesterday marked one year since the first COVID-19 case was recorded in the country.
The Department of Health has come under fire from some opposition parties in Parliament who accuse it of acting improperly by claiming it is rolling out the Johnson and Johnson vaccine, when it is merely part of a study.
The South African Health Products Regulatory Authority (SAHPRA) says it is at an advanced stage of reviewing an emergency use application for Pfizer's COVID-19 vaccine.
The SAPS says more arrests are imminent as authorities have seized hundreds of fake COVID-19 vaccines following a global alert issued by Interpol.
The African Center for Disease Control and Prevention’s (Africa CDC) Dr Nicaise Ndemi says Africa is making remarkable progress in its vaccine rollout programs.
Professor of Vaccinology at the University of the Witwatersrand says the government should use the doses of the AstraZeneca vaccine.
Deputy Health Minister Dr Joe Phaahla says the government has not prevented the private sector from purchasing coronavirus vaccines.